GAN & LEE PHARMACEUTICALS. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.63 CNY | +1.13% |
|
+7.11% | -13.33% |
| Jun. 17 | Gan & Lee Pharmaceuticals.(SHSE:603087) added to SSE 180 Index | CI |
| Jun. 17 | Gan & Lee Pharmaceuticals.(SHSE:603087) added to Shanghai Stock Exchange 180 Value Index | CI |
Chart calendar Gan & Lee Pharmaceuticals.
51a8b9db2338016.rnSvDLXI2D7r5YA7B8_zVyJR-bH8XHexAU2KTDqhL-s.1jLrVYeCqXGc0rh4Pvy0bhoSyeexLzLwORvAFAmQQNjBAu1-7am-cbG61Q~b78b91dc3d5b7fa92cb16a092ef0a86e
Upcoming events on Gan & Lee Pharmaceuticals.
Past events on Gan & Lee Pharmaceuticals.
| 2024-05-16 02:00 am | Annual General Meeting |
| 2024-04-24 | Q1 2024 Earnings Release |
| 2024-04-24 | Q4 2023 Earnings Release |
| 2024-03-11 01:00 am | Extraordinary Shareholders Meeting |
| 2023-10-30 | Q3 2023 Earnings Release |
| 2023-09-11 02:00 am | Extraordinary Shareholders Meeting |
| 2023-08-24 | Q2 2023 Earnings Release |
| 2023-04-27 | Q1 2023 Earnings Release |
| 2023-04-19 | Annual General Meeting |
| 2023-03-30 | Q4 2022 Earnings Release |
| 2023-03-13 02:00 am | Extraordinary Shareholders Meeting |
| 2022-11-15 01:00 am | Extraordinary Shareholders Meeting |
| 2022-10-27 | Q3 2022 Earnings Release |
| 2022-08-25 | Interim 2022 Earnings Release |
| 2022-05-19 02:00 am | Annual General Meeting |
| 2022-04-27 | Q1 2022 Earnings Release |
| 2022-04-27 | FY 2021 Earnings Release |
| 2021-10-27 | Q3 2021 Earnings Release |
| 2021-10-19 02:00 am | Extraordinary Shareholders Meeting |
| 2021-09-30 05:45 am | European Association for the Study of Diabetes Meeting |
Past dividends on Gan & Lee Pharmaceuticals.
| 2024-06-17 | Annual 0.2 CNY |
| 2022-06-19 | Annual 0.3 CNY |
| 2021-05-20 | Annual 0.4 CNY |
| 2020-08-19 | Annual 0.5 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 895 | 3 362 3 431 -2.01% | 3 612 3 786 -4.59% | 0,00 | 2 608 2 585 0.88% | 3 628 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 538 584 -7.93% | 961 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | 1 453 1 518 -4.29% | 1 699 1 694 0.29% | 0,00 | 315 413 -23.66% | 759 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | 1 445 1 518 -4.78% | 1 696 1 687 0.53% | 0,00 | 306 417 -26.58% | 751 |
|
Net income Million CNY | Released Forecast Spread | 0,00 | 1 231 1 269 -3.02% | 1 453 1 436 1.17% | -440 | 340 322 5.73% | 710 |
|
EPS CNY | Released Forecast Spread | 2,31 | 2,31 2,33 -0.86% | 2,59 2,56 1.17% | -0,78 | 0,60 0,53 13.21% | 1,20 |
| Announcement Date | 07/06/20 | 14/04/21 | 27/04/22 | 30/03/23 | 24/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 702 699 0.51% | 560 654 -14.29% | 792 | 1 029 | 1 414 | 673 | |
|
EBIT Million CNY | Released Forecast Spread | -1,93 | 113 | |||||
|
Net income Million CNY | Released Forecast Spread | 132 | ||||||
|
EPS CNY | Released Forecast Spread | 0,23 | 0,13 0,08 62.5% | 0,16 0,23 -30.43% | 0,35 | 0,31 | 0,46 | 0,32 |
| Announcement Date | 30/10/23 | 24/04/24 | 24/04/24 | - | - | - | - |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | GRIFOLS, S.A.: Q2 2024 Earnings Release |
| 2024-07-29 | BIOTEST AG: Q2 2024 Earnings Release |
| 2024-07-30 07:00 am | INCYTE CORPORATION: Q2 2024 Earnings Release |
Past sector events for Gan & Lee Pharmaceuticals.
| Today 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-05-23 05:43 am | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-13 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603087 Stock
- Calendar Gan & Lee Pharmaceuticals.
